Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.506ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.506ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.506NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.482ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.482ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.482ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.482NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.335ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.335ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.335ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.335NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-12070.6US
B.1.499.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.499.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.499.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.499.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.116ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.116ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.116ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.116NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.134ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.134ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.134NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.393ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.393ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.393ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.393NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.381ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.381ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.381ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.381NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AE.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AE.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.516ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.516ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.516ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used